Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Yoshida

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|June 21, 2018
Quantitative Prediction of OATP-Mediated Drug-Drug Interactions With Model-Based Analysis of Endogenous Biomarker KineticsKenta Yoshida, Cen Guo, Rucha Sane
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2025
Disease Modeling and External Model Evaluation Through Clinical Data Sharing Platform for HR+/HER2- Breast CancerKenta Yoshida, René Bruno, Pascal Chanu
Journal of Electron Microscopy|February 28, 2012
Direct observation of the initial process of Ostwald ripening using spherical aberration-corrected transmission electron microscopyKenta Yoshida, Alexander Bright, Nobuo Tanaka
Annual Review of Pharmacology and Toxicology|November 13, 2012
Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphismsKenta Yoshida, Kazuya Maeda, Yuichi Sugiyama
Langmuir : the ACS Journal of Surfaces and Colloids|July 9, 2016
Supramolecular Chirality: Vesicle-to-Chiral Helix Transition of the Micelles Consisting of a Sugar-Bearing Calix[4]arene SurfactantShunsuke Sakamoto, Shota Fujii, Kenta Yoshida, et al.
BMC Systems Biology|February 22, 2014
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic modelsKenta Yoshida, Kazuya Maeda, Hiroyuki Kusuhara, et al.
NPJ Precision Oncology|April 14, 2025
Predicting survival in prospective clinical trials using weakly-supervised QSPMatthew West, Kenta Yoshida, Jiajie Yu, et al.
Drug Metabolism and Pharmacokinetics|July 11, 2014
A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibioticsYoshiaki Kitamura, Kenta Yoshida, Makiko Kusama, et al.
American Journal of Obstetrics and Gynecology|November 23, 2025
Laparoscopic trans-broad-ligament abdominal cerclage with round ligament suspension to create a space in the pouch of Douglas (LAC-D) during pregnancyMasafumi Nii, Kenta Yoshida, Eiji Kondo, et al.
Journal of Clinical Pharmacology|July 8, 2016
Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1Jayabharathi Vaidyanathan, Kenta Yoshida, Vikram Arya, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
CPT: Pharmacometrics & Systems Pharmacology|June 21, 2018
Quantitative Prediction of OATP-Mediated Drug-Drug Interactions With Model-Based Analysis of Endogenous Biomarker KineticsKenta Yoshida, Cen Guo, Rucha Sane
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2025
Disease Modeling and External Model Evaluation Through Clinical Data Sharing Platform for HR+/HER2- Breast CancerKenta Yoshida, René Bruno, Pascal Chanu
Journal of Electron Microscopy|February 28, 2012
Direct observation of the initial process of Ostwald ripening using spherical aberration-corrected transmission electron microscopyKenta Yoshida, Alexander Bright, Nobuo Tanaka
Annual Review of Pharmacology and Toxicology|November 13, 2012
Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphismsKenta Yoshida, Kazuya Maeda, Yuichi Sugiyama
Langmuir : the ACS Journal of Surfaces and Colloids|July 9, 2016
Supramolecular Chirality: Vesicle-to-Chiral Helix Transition of the Micelles Consisting of a Sugar-Bearing Calix[4]arene SurfactantShunsuke Sakamoto, Shota Fujii, Kenta Yoshida, et al.
BMC Systems Biology|February 22, 2014
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic modelsKenta Yoshida, Kazuya Maeda, Hiroyuki Kusuhara, et al.
NPJ Precision Oncology|April 14, 2025
Predicting survival in prospective clinical trials using weakly-supervised QSPMatthew West, Kenta Yoshida, Jiajie Yu, et al.
Drug Metabolism and Pharmacokinetics|July 11, 2014
A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibioticsYoshiaki Kitamura, Kenta Yoshida, Makiko Kusama, et al.
American Journal of Obstetrics and Gynecology|November 23, 2025
Laparoscopic trans-broad-ligament abdominal cerclage with round ligament suspension to create a space in the pouch of Douglas (LAC-D) during pregnancyMasafumi Nii, Kenta Yoshida, Eiji Kondo, et al.
Journal of Clinical Pharmacology|July 8, 2016
Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1Jayabharathi Vaidyanathan, Kenta Yoshida, Vikram Arya, et al.
Pageof 17